| Literature DB >> 35445211 |
Clemence Bonnefoy1, Mathieu Nacher2,3, Gerald Egmann1, Agathe Pastre4,5, Vincent About1,5, Daniel Jeanbourquin6, Dominique Louvel7, Karim Hamiche4, Timothee Bonifay2,5.
Abstract
Background: French Guiana is used as a drug trafficking pipeline of cocaine to Europe. The number of arrests for transporting cocaine in corpore has increased exponentially in recent years. Since 2010, Cayenne Hospital's emergency care unit has applied a medical management protocol system for body-packers. Our objective was to describe the epidemiology of body-packers and to evaluate medical management. Method: A retrospective descriptive study was performed among patients hospitalized in Cayenne Hospital for transporting cocaine in corpore between January 2010 and November 2015. In addition, a qualitative study including interviews of body-packers imprisoned in Rémire-Montjoly prison was conducted in April 2016. Result: A total of 282 patients were included in the study. The median age was 24 years and the sex ratio M/W was to 4/1. Among them, 3.5% showed signs of severity (9 with pre-existing condition and 1 with severe form). No surgery or deaths were reported. Ten endoscopies were performed because of the delay in evacuation without complications. Approximately 28% of patients had urinary screening, of which 60.7% were positive. The median length of stay was 1.8 days. Prolonged length of stay was significantly associated with the presence of gastrointestinal symptoms, hypoglycemia, or having swallowed a minimum of 10 pellets.Entities:
Keywords: French Guiana; body packer; body packing; cocaine; drug; mule
Year: 2022 PMID: 35445211 PMCID: PMC9013264 DOI: 10.1002/emp2.12603
Source DB: PubMed Journal: J Am Coll Emerg Physicians Open ISSN: 2688-1152
FIGURE 1Flow chart of the study
FIGURE 2Number of confirmed body‐packing patients hospitalized at Cayenne Hospital per year (n = 282)
Symptoms that may be associated with cocaine poisoning
| Clinical data | No. |
|---|---|
| Malaise | 1 |
| Chest pain | 2 |
| Mydriasis | 2 |
| Mydriasis and vomiting | 1 |
| Agitation and headache | 1 |
| Disorders of rhythm (AVB1, EVS) | 2 |
| Total | 9 |
AVB, atrio‐ventricular block; EVS, extra ventricular systoles.
Bivariate analysis for stays >4 days
| Hospitalization >4 days (%), n = 36 | Hospitalization ≤4 days (%), n = 246 | OR (95% CI) |
| |
|---|---|---|---|---|
| Male | 29/36 (80.5) | 199/246 (80.8) | 0.97 (0.38–2.8) | 0.90 |
| Fever | 0/32 | 5/216 (3.96) | 0 (0–5.23) | 0.38 |
| Tachycardia | 12/36 (33.3) | 80/241 (33.1) | 1.00 (0.43–2.22) | 0.98 |
| High blood pressurea | 15/36 (41.6) | 135/240 (56.3) | 0.55 (0.25–1.19) | 0.10 |
| Digestive signs | 11/34 (32.3) | 22/215 (10.2) | 4.19 (1.61–10.4) | <0.01 |
| No. pellets ≥10 | 34/36 (94.4) | 162/232 (69.8) | 7.34 (1.78–64) | <0.01 |
| Gastric pellets | 11/25 (44) | 54/185 (29.2) | 1.9 (0.73–4.8) | 0.13 |
| Laxative intake | 35/36 (97.2) | 226/236 (95.7) | 1.5 (0.2–69) | 0.67 |
| Hypoglycemia | 5/24 (20) | 5/96 (5.2) | 4.79 (0.07–22.7) | 0.01 |
95% CI, 95% confidence interval; OR, odds ratio.
aSigns presents during first evaluation.